I’ve built AI where mistakes have consequences.
I’m Mohammad Haft-Javaherian, founder of Haft Advisors.
For five years I led machine learning at Iterative Health, the company behind SKOUT, an FDA-cleared AI device that helps doctors find polyps during colonoscopy. I grew from Manager of ML to Head of ML, built a 28-person organization of ML scientists, engineers, and medical data operations staff, and reported to the CEO. We took SKOUT through multiple FDA 510(k) clearances and into national commercial sales.
Along the way I led the technical side of AI partnerships with Eli Lilly, Pfizer, and others, including AI endpoints for Lilly’s ulcerative colitis trials, delivered on budget across Phase I and II and extended into Phase III under a five-year agreement.
Before industry, I earned a PhD in Biomedical Engineering at Cornell and was a postdoctoral fellow at Massachusetts General Hospital, Harvard Medical School, and MIT CSAIL. I’ve published 51 papers, with more than 1,400 citations.
I started Haft Advisors because most companies don’t need a full-time AI executive yet. They need someone who has already made the hard calls (what to build, who to hire, when a model is ready, what regulators will ask) and can make them alongside the CEO.